Literature DB >> 21565290

Role of microRNAs in hepatitis B virus replication and pathogenesis.

Wan-Hsin Liu1, Shiou-Hwei Yeh, Pei-Jer Chen.   

Abstract

The hepatitis B virus (HBV) is a widespread human pathogen and chronic HBV infection is a major risk factor for hepatocellular carcinoma (HCC). The role of microRNA (miRNA) in the replication and pathogenesis was reviewed. So far none of HBV-encoded miRNA has been identified. Cellular miRNAs have shown able to regulate HBV at the transcription level either by targeting to cellular transcriptions factors required for HBV gene expression, or by a directly binding to HBV transcripts. We also summarized the changed patterns of cellular miRNAs from hepatitis B progressing to cirrhosis and then liver cancer. The changing of a few of miRNAs, such as miR-122 or miR-21, were reproduced and worthy of further research by a deep sequencing and functional validation. These HBV-specific miRNAs should potentially become biomarkers for HBV infection and HBV-positive HCC diagnosis. The understanding of miRNA biology paved the way for applying miRNAs-based RNAi against HBV replication with minimal toxicities. This article is part of a Special Issue entitled: MicroRNAs in viral gene regulation. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565290     DOI: 10.1016/j.bbagrm.2011.04.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  MicroRNA-125b-5p mediates post-transcriptional regulation of hepatitis B virus replication via the LIN28B/let-7 axis.

Authors:  Wanyu Deng; Xiaoyong Zhang; Zhiyong Ma; Yong Lin; Mengji Lu
Journal:  RNA Biol       Date:  2017-03-07       Impact factor: 4.652

Review 2.  X region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 3.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

4.  MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection.

Authors:  Er-Lei Zhang; Jin Gu; Zun-Yi Zhang; Ke-Shuai Dong; Bin-Yong Liang; Zhi-Yong Huang
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

5.  Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.

Authors:  Guang-Hui Liu; Zong-Guang Zhou; Rong Chen; Mon-Jin Wang; Bin Zhou; Yuan Li; Xiao-Feng Sun
Journal:  Tumour Biol       Date:  2013-04-28

Review 6.  Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication.

Authors:  Yoshiaki Mizuguchi; Toshihiro Takizawa; Eiji Uchida
Journal:  World J Hepatol       Date:  2015-04-08

Review 7.  Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy.

Authors:  Li-Li Han; Yi Lv; Hui Guo; Zhi-Ping Ruan; Ke-Jun Nan
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 8.  Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity.

Authors:  Xia Jiang; Tatsuo Kanda; Shuang Wu; Masato Nakamura; Tatsuo Miyamura; Shingo Nakamoto; Arup Banerjee; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 9.  Roles of hepatocyte nuclear factors in hepatitis B virus infection.

Authors:  Doo Hyun Kim; Hong Seok Kang; Kyun-Hwan Kim
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

10.  Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes.

Authors:  Yanling Wang; Li Jiang; Xiong Ji; Bo Yang; Yi Zhang; Xiang-Dong Fu
Journal:  J Biol Chem       Date:  2013-05-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.